F. Vandenberghe

发表

Second-Generation Antipsychotics in Adolescent Psychiatric Patients: Metabolic Effects and Impact of an Early Weight Change to Predict Longer Term Weight Gain.

C. Eap, P. Conus, L. Holzer, 2018, Journal of child and adolescent psychopharmacology.

Impact of drugs on hypoglycaemia in hospitalised patients

L. Christin, F. Vandenberghe, C. Challet, 2018, European journal of hospital pharmacy. Science and practice.

Prediction of early weight gain during psychotropic treatment using a combinatorial model with clinical and genetic markers

C. Eap, A. von Gunten, P. Conus, 2016, Pharmacogenetics and genomics.

Insomnia disorders are associated with increased cardiometabolic disturbances and death risks from cardiovascular diseases in psychiatric patients treated with weight-gain-inducing psychotropic drugs: results from a Swiss cohort

C. Eap, A. von Gunten, K. Plessen, 2022, BMC Psychiatry.

Association of CRTC1 polymorphisms with obesity markers in subjects from the general population with lifetime depression.

M. Preisig, B. Penninx, G. Willemsen, 2016, Journal of affective disorders.

Psychological trauma occurring during adolescence is associated with an increased risk of greater waist circumference in Early Psychosis patients treated with psychotropic medication

K. Do, C. Eap, P. Conus, 2020, PloS one.

Genetics-Based Population Pharmacokinetics and Pharmacodynamics of Risperidone in a Psychiatric Cohort

C. Eap, A. Gunten, P. Conus, 2015, Clinical Pharmacokinetics.

Olanzapine‐associated dose‐dependent alterations for weight and metabolic parameters in a prospective cohort

E. Seifritz, C. Eap, A. von Gunten, 2022, Basic & clinical pharmacology & toxicology.

The psychosis metabolic risk calculator (PsyMetRiC) for young people with psychosis: International external validation and site-specific recalibration in two independent European samples

B. Crespo-Facorro, E. Fernandez-Egea, G. Murray, 2022, The Lancet regional health. Europe.

Bioavailability of Vortioxetine After a Roux-en-Y Gastric Bypass

Y. Daali, C. Eap, L. Favre, 2020, Obesity Surgery.

Tools for optimising pharmacotherapy in psychiatry (therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests): focus on antidepressants

E. Corruble, R. Lanzenberger, J. Meyer, 2021, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Association of genetic risk scores with body mass index in Swiss psychiatric cohorts

Z. Kutalik, C. Eap, A. von Gunten, 2016, Pharmacogenetics and genomics.

Early changes of blood lipid levels during psychotropic drug treatment as predictors of long-term lipid changes and of new onset dyslipidemia.

C. Eap, A. von Gunten, J. Aubry, 2017, Journal of clinical lipidology.

Association of PCK1 with Body Mass Index and Other Metabolic Features in Patients With Psychotropic Treatments

Z. Kutalik, P. Magistretti, M. Preisig, 2015, Journal of clinical psychopharmacology.

Association of variants in SH2B1 and RABEP1 with worsening of low-density lipoprotein and glucose parameters in patients treated with psychotropic drugs.

L. Applegate, C. Eap, A. von Gunten, 2017, Gene.

Influence of polygenic risk scores on lipid levels and dyslipidemia in a psychiatric population receiving weight gain-inducing psychotropic drugs

C. Eap, A. von Gunten, P. Conus, 2017, Pharmacogenetics and genomics.

Association Between Plasma Caffeine and Other Methylxanthines and Metabolic Parameters in a Psychiatric Population Treated With Psychotropic Drugs Inducing Metabolic Disturbances

M. Bochud, I. Guessous, C. Eap, 2018, Front. Psychiatry.

Impact of HSD11B1 polymorphisms on BMI and components of the metabolic syndrome in patients receiving psychotropic treatments

Z. Kutalik, P. Magistretti, M. Preisig, 2015, Pharmacogenetics and genomics.

Genetic immune and inflammatory markers associated with diabetes in solid organ transplant recipients

Z. Kutalik, P. Vollenweider, J. Dufour, 2018, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Clinical Pharmacy in Psychiatry: Towards Promoting Clinical Expertise in Psychopharmacology

C. Hingray, H. Javelot, S. Weibel, 2021, Pharmacy.

Importance of early weight changes to predict long-term weight gain during psychotropic drug treatment.

C. Eap, A. von Gunten, P. Conus, 2015, The Journal of clinical psychiatry.

Influence of CRTC1 polymorphisms on body mass index and fat mass in psychiatric patients and the general adult population.

J. Beckmann, Z. Kutalik, P. Magistretti, 2013, JAMA psychiatry.

Identification of four novel loci associated with psychotropic drug-induced weight gain in a Swiss psychiatric longitudinal study: A GWAS analysis

Z. Kutalik, C. Eap, A. von Gunten, 2023, Molecular Psychiatry.

Influence of MCHR2 and MCHR2-AS1 Genetic Polymorphisms on Body Mass Index in Psychiatric Patients and In Population-Based Subjects with Present or Past Atypical Depression

Z. Kutalik, P. Magistretti, M. Preisig, 2015, PloS one.

The Influence of a Roux-en-Y Gastric Bypass on Plasma Concentrations of Antidepressants

C. Eap, N. Vionnet, L. Favre, 2023, Obesity Surgery.

Associations Between High Plasma Methylxanthine Levels, Sleep Disorders and Polygenic Risk Scores of Caffeine Consumption or Sleep Duration in a Swiss Psychiatric Cohort

M. Bochud, C. Eap, A. von Gunten, 2021, Frontiers in Psychiatry.

Use of pharmacological treatment for posttraumatic stress disorder: Analysis of a psychiatric population in Switzerland and comparison with international guidelines.

C. Eap, F. Montavon, F. Vandenberghe, 2022, L'Encephale.

Association of genetic risk scores with body mass index in Swiss psychiatric cohorts

Z. Kutalik, C. Eap, L. Quteineh, 2016, Pharmacogenetics and genomics.

Optimisation of pharmacotherapy in psychiatry through therapeutic drug monitoring, molecular brain imaging and pharmacogenetic tests: focus on antipsychotics.

S. Nakajima, S. Crettol, F. Vandenberghe, 2024, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Therapeutic Drug Monitoring of Olanzapine: Effects of Clinical Factors on Plasma Concentrations in Psychiatric Patients.

S. Crettol, F. Vandenberghe, N. Ansermot, 2024, Therapeutic drug monitoring.